Drugs / HL 10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00742482 | Jan 2003 → Jan 2005 | acute lung injury, acute respiratory distress syndrome | LEO Pharma | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HL 10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00742482 ↗ |
| Modality | Protein / enzyme biologic | “We randomly assigned 418 patients to receive usual care either with or without instillation of exogenous natural porcine surfactant HL 10 as large boluses.” PMID 19713451 ↗ Aug 2009 |
| Route | Other | “Intratracheal surfactant replacement induces a significant and prolonged lung reaeration.” PMID 20633284 ↗ Jul 2010 |